CRMD vs STZ · P/E 3.9, rev $43.5M vs P/E 14, rev $9.14B
CorMedix Inc (CRMD) versus Constellation Brands Inc Class A (STZ) — a side-by-side from cached financials, not a winner call.
CorMedix Inc (CRMD) is a biotechnology company listed on US.
Constellation Brands Inc Class A (STZ) is a beverages - brewers company listed on US.
Latest reported CRMD revenue for 2024-12-31 was $43.5M. Net income was -$17.9M. Revenue was up 66363.1% from 2022-12-31 to 2024-12-31. CRMD currently screens at market cap $655.9M and trailing P/E 3.9.
Latest reported STZ revenue for 2026-02-28 was $9.14B. Net income was $1.69B. Revenue was up 322.3% from 2025-02-28 to 2026-02-28. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
CRMD currently screens at market cap $655.9M and trailing P/E 3.9. STZ currently screens at market cap $23.73B and trailing P/E 14.4.
Not investment advice. Open the CRMD and STZ stock pages for the full models.
Not investment advice.